Viridian Therapeutics, Inc.DE (VRDN) earnings date
Feb 25, 2027, before open estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 45% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-18
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 36 days, typically, give or take 10 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Wed, Nov 4, 2026 | before open | 35 | 8-K |
| Q2 FY2026 | Thu, Aug 6, 2026 | before open | 37 | 8-K |
| Q1 FY2026 | Tue, May 5, 2026 | before open | 35 | 8-K |
| Q4 FY2025 | Thu, Feb 26, 2026 | before open | 57 | 8-K |
| Q3 FY2025 | Wed, Nov 5, 2025 | before open | 36 | 8-K |
| Q2 FY2025 | Wed, Aug 6, 2025 | before open | 37 | 8-K |
| Q1 FY2025 | Tue, May 6, 2025 | before open | 36 | 8-K |
| Q4 FY2024 | Thu, Feb 27, 2025 | before open | 58 | 8-K |
What they guided beta
| Q3 FY2026 | "Exhibit 99.1 Viridian Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Recent Business Progress - $24.7 million in Lumvoa ™ (veligrotug-vvze) net product revenue with more than 100 patients on therapy at the end of Q3 2026 - - Elegrobart Biologics License Application (BLA) submission on track for Q1 2027 - - VRDN-008 phase 1 data disclosure on track for Q4 2026 - - VRDN-292, a potential best-in-class TSHR inhibitor, expected to initiate a phase 1 clinical trial in patients in Q4 2026 - - Cash, cash equivalents, and marketable securities of $955.2 million as of Se" exhibit |
| Q3 FY2026 | "Viridian expects to submit a BLA to the U.S. FDA for elegrobart in TED in Q1 2027." exhibit |
| Q3 FY2026 | "VRDN-292: IND on track to initiate a phase 1 clinical trial in patients in Q4 2026" exhibit |
| Q3 FY2026 | "VRDN-292 IND on track to support phase 1 clinical trial initiation in Q4 2026, starting in patients with Graves’ disease." exhibit |
| Q3 FY2026 | "FcRn update on track for Q4 2026: Viridian expects to announce VRDN-008 phase 1 healthy volunteer data and development plans for the FcRn portfolio in Q4 2026." exhibit |
| Q2 FY2026 | "In parallel, we continue to advance our R&D pipeline toward a planned BLA submission for elegrobart in the first quarter of 2027, and are on track to deliver on clinical development milestones for our FcRn and TSHR programs in the second half of this year." exhibit |
| Q2 FY2026 | "Viridian is on track to submit a Biologics License Application (BLA) to the FDA for elegrobart in Q1 2027." exhibit |
| Q2 FY2026 | "Viridian plans to submit an Investigational New Drug (IND) application in Q4 2026 and expects to develop this program in TED and Graves’ disease." exhibit |
| Q2 FY2026 | "VRDN-008: phase 1 healthy volunteer data expected in 2H 2026" exhibit |
| Q2 FY2026 | "Viridian anticipates sharing development plans for VRDN-006 in 2026." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/VRDN
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/VRDN
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/VRDN/"><img src="https://veritasdata.dev/embed/VRDN.svg" alt="VRDN earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/VRDN/)
Script
<script async src="https://veritasdata.dev/embed/VRDN.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/VRDN"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.